The abstract is read at the publisher; the summary is JClub's.
Docosanoic acid–conjugated allele-selective ACVR1 R206H siRNA reduces heterotopic ossification in a murine fibrodysplasia ossificans progressiva model, and adding IL-1β targeting improves suppression.
- Why it matters: The ACVR1 R206H mutation drives inflammatory flare-ups that trigger debilitating heterotopic ossification, and current approaches lack allele selectivity that preserves normal ACVR1 function.
- What they did: Mice received post-trauma or preventative dosing with ACVR1 R206H siRNA alone or combined with an IL-1β–targeting siRNA; the study also tested a single lipophilic divalent molecule combining both targets.
- The result: Combination therapy reduced cartilage, bone, and connective tissue formation and suppressed inflammatory and multiple developmental signaling pathways in fibroadipogenic progenitors, while the divalent compound matched combined monovalent efficacy with equimolar dosing.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.